ADDENTAX GROUP CORP. (ATXG): Nasdaq/NYSE listing notice — Addentax receives Nasdaq notice for bid price below $1.00; 180-day cure period

ADDENTAX GROUP CORP.

Nasdaq notification on April 24, 2024, due to bid price below $1.00 for 30 consecutive business days.
Company has 180 days, until October 21, 2024, to regain compliance; trading continues under ATXG.
If not compliant by Oct 21, may request additional 180-day period and consider reverse stock split.
To qualify for second grace period, must meet all other initial listing standards for Nasdaq Capital Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ADDENTAX GROUP CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 24, 2024, from the Listings Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share of its ordinary shares was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). The Nasdaq notification letter does not result in the immediate delisting of the Company’s ordinary shares, and the shares will continue to trade uninterrupted under the symbol “ATXG.” Pursuant to

View on SEC.gov

97 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ADDENTAX GROUP CORP. filing history →

Source: SEC EDGAR

accession 0001493152-24-015872

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.